US$ 27.24
glp-1 news oct 9 2025 Receptor Agonist Market Valued at USD 62.86 Billion in 2025, Set to Grow at 17.5% CAGR Through 2034 GLP-1 Market Overview 2025
Description
Oral semaglutide is associated with a low risk of hypoglycaemia because it stimulates insulin secretion according to glucose plasma levels, making this drug suitable for elderly individuals [82]

Insurance companies definitely dont cover the cost for the merely overweight

Conte C et al
Even if a person only wants to lose 10 pounds, a full medical review is often necessary before considering these medications

For brand-name injectable medications, Nurx sends prescriptions to the patients local pharmacy of choice

This resulted in a shortage of the medication to dispense to diabetic patients